Literature DB >> 8055097

Generation of alginate-poly-l-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions.

X Ma1, I Vacek, A Sun.   

Abstract

Alginate-poly-l-lysine-alginate (APA) microcapsules have proven effective in protecting enclosed live cells from immune rejection following transplantation into experimental animals, thereby eliminating the need for immunosuppressive therapy. However, in order for the capsules to remain intact for extended periods in vivo, the thickness of the membrane material must be optimized. In this study, the membrane thickness was examined as an indicator of membrane strength and measured under different reaction conditions. The thickness was found to increase 1) from 4.6 microns to 6.6 microns with an increase in the concentration of sodium alginate from 1.25 (w/v) to 2.0% (w.v); 2) from 4.2 microns to 6.2 microns with an increase in the concentration of the calcium solution from 20 mM to 100mM; 3) from 3.9 microns to 10.3 microns with an increase in the concentration of poly-l-lysine (PLL) from 0.02% (w/v) to 0.08% (w/v); and 4) from 2.3 microns to 7.4 microns with an increase in the reaction time with the PLL from two to seven minutes. On the other hand, membrane thickness decreased 1) from 9.8 microns to 8.6 microns with an increase of the pH in the PLL solution from 5.8 to 9.2; 2) from 13.2m to 5.8 microns with an increase in the molecular weight of PLL from 14,000 to 57,000; 3) from 8.4 microns to 6.0 microns with an increase in the treatment time with 0.9 (w/v) NaCl solution from zero to fifteen minutes and; 4) from 7.5 microns to 6.1 microns with an increase in the treatment time of the second sodium alginate coating from zero to ten minutes. Membrane thickness was inversely proportional to capsule volume expansion during membrane synthesis. By replacing calcium chloride by calcium lactate and eliminating the use of CHES in the construction of capsule membranes, we improved the strength and biocompatibility of our capsules, as evidenced by marked improvements in the survival rates of diabetic mice treated with islet transplants enclosed in the new capsules. These results indicate that it is possible to obtain optimal membrane thickness for a given purpose by creating specific reaction conditions under which membranes are synthesized.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8055097     DOI: 10.3109/10731199409117399

Source DB:  PubMed          Journal:  Artif Cells Blood Substit Immobil Biotechnol        ISSN: 1073-1199


  9 in total

1.  Microencapsulated tumor assay: evaluation of the nude mouse model of pancreatic cancer.

Authors:  Ming-Zhe Ma; Dong-Feng Cheng; Jin-Hua Ye; Yong Zhou; Jia-Xiang Wang; Min-Min Shi; Bao-San Han; Cheng-Hong Peng
Journal:  World J Gastroenterol       Date:  2012-01-21       Impact factor: 5.742

2.  Transferrin receptor targeted lipopolyplexes for delivery of antisense oligonucleotide g3139 in a murine k562 xenograft model.

Authors:  Xulang Zhang; Chee Guan Koh; Bo Yu; Shujun Liu; Longzhu Piao; Guido Marcucci; Robert J Lee; L James Lee
Journal:  Pharm Res       Date:  2009-03-17       Impact factor: 4.200

3.  A naonoporous cell-therapy device with controllable biodegradation for long-term drug release.

Authors:  Hongyan He; Eric Luedke; Xulang Zhang; Bo Yu; Alessandra Schmitt; Ben McClarren; Valerie Grignol; William E Carson; L James Lee
Journal:  J Control Release       Date:  2012-12-07       Impact factor: 9.776

4.  Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression.

Authors:  Y Sun; X Ma; D Zhou; I Vacek; A M Sun
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

Review 5.  Natural polymers for the microencapsulation of cells.

Authors:  Luca Gasperini; João F Mano; Rui L Reis
Journal:  J R Soc Interface       Date:  2014-11-06       Impact factor: 4.118

6.  Encapsulating non-human primate multipotent stromal cells in alginate via high voltage for cell-based therapies and cryopreservation.

Authors:  Oleksandr Gryshkov; Denys Pogozhykh; Nicola Hofmann; Olena Pogozhykh; Thomas Mueller; Birgit Glasmacher
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

7.  Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

Authors:  Satya Prakash; Aleksandra Malgorzata Urbanska
Journal:  Biologics       Date:  2008-09

8.  The role of osmolarity adjusting agents in the regulation of encapsulated cell behavior to provide a safer and more predictable delivery of therapeutics.

Authors:  Ainhoa Gonzalez-Pujana; Aitor Rementeria; Francisco Javier Blanco; Manoli Igartua; Jose Luis Pedraz; Edorta Santos-Vizcaino; Rosa Maria Hernandez
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

9.  Alginate nanoparticles as a promising adjuvant and vaccine delivery system.

Authors:  F Sarei; N Mohammadpour Dounighi; H Zolfagharian; P Khaki; S Moradi Bidhendi
Journal:  Indian J Pharm Sci       Date:  2013-07       Impact factor: 0.975

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.